4

4D Molecular Therapeutics

Develops gene therapies using AAV vectors

Senior Director of Clinical Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRemote in USA$245k - $286k

About the Job

Requirements

  • A bachelor's degree in a life science, nursing, pharmacy, or related field is required; an advanced degree (MS, PharmD, or PhD) is preferred.
  • Experience in Ophthalmology is highly desired.
  • At least 12 years of experience, or an advanced degree with at least 10 years of experience, in a regulated environment such as Regulatory, Quality, Pharmacovigilance, or Clinical Development/Operations within the Biotech or similar industry.
  • Proven experience leading Clinical quality strategy, quality governance, and senior-level quality oversight of global clinical trials and associated vendors.
  • At least 7 years of significant clinical quality assurance experience, including leading, performing, and/or providing senior oversight of GCP audits and global clinical trials.
  • Experience hosting, leading, and supporting health authority inspections, including inspection-readiness preparation, front-room/back-room support, response coordination, and follow-up commitment management.
  • Extensive practical experience and understanding of clinical quality assurance throughout the clinical development life cycle.
  • Demonstrated ability to influence senior cross-functional stakeholders, lead complex clinical quality initiatives, and provide mentorship or functional leadership within Clinical QA.
  • Expert understanding of GCP requirements for investigational products and the ability to interpret and apply requirements strategically across clinical programs.
  • Executive-level oral and written communication skills, with the ability to present quality risks, recommendations, and inspection-readiness status to senior stakeholders.
  • Strong leadership, influencing, and interpersonal skills, with a collaborative approach to driving alignment across Clinical, Quality, Regulatory, and external vendor stakeholders.
  • Ability to operate independently in a fast-paced small-company environment, prioritize complex workstreams, make risk-based decisions with minimal direction, and adjust quickly to changing business priorities.

Responsibilities

  • Provide strategic Quality leadership and oversight for multiple 4DMT clinical studies, including study-specific quality activities.
  • Serve as a senior Quality partner to clinical study teams and leadership, providing guidance on GCP, ICH E6, and related regulations and guidance, decision support, and escalation recommendations through study-team meetings, quality governance forums, and escalation discussions concerning Clinical Study Quality Events.
  • Lead the development, implementation, and governance of Clinical Study Quality Plans for specific 4DMT clinical studies, protecting subject safety and rights, data integrity, and GCP compliance across assigned studies and associated vendors.
  • Manage, mentor, and develop Clinical QA staff and consultants; establish clear goals, development plans, and succession depth.
  • Define, plan, perform, and/or oversee risk-based GCP compliance audits of high-risk clinical vendors and sites, including clinical investigator sites.
  • Communicate audit findings, quality risks, and CAPA commitments to senior stakeholders; collaborate with auditees and vendors to track, review, and approve CAPAs, assess their adequacy, and ensure timely escalation of unresolved or recurring issues.
  • Provide senior Quality review and strategic input on clinical documents to ensure quality, accuracy, completeness, and inspection readiness of key clinical and regulatory documents, including, as applicable, Clinical Protocols, IBs, DSURs, Module 2.6 and 2.7 Tabulated and Written Summaries, and Integrated Summaries.
  • Identify, communicate, and escalate significant incidents of GCP non-compliance, quality risks, and inspection-readiness concerns; drive timely resolution and ensure appropriate executive visibility, escalation, and risk-based decision-making.
  • Provide QA oversight for formal corrective and preventive actions (CAPAs), ensuring actions are risk-based, effective, timely, and appropriately escalated to address Clinical Study Quality Events, including potential serious breaches of GCP.
  • Partner with CMC Quality, Clinical Operations, and senior cross-functional stakeholders to investigate, escalate, and resolve clinical supply quality issues, including temperature excursions, product complaints, and deviations reported from clinical sites; ensure appropriate risk assessment, stakeholder communication, and CAPA linkage when applicable.
  • Oversee and provide strategic direction for developing GCP compliance training materials and delivering training to strengthen clinical quality culture and inspection readiness.
  • Partner with Clinical Operations, Clinical Development, Biometrics, Data Management, Medical Affairs, and Regulatory Affairs to embed proactive quality and risk management into study design and conduct.
  • Lead development and continuous improvement of the Clinical Quality Management system through developing and refining Clinical QA processes.
  • Define and lead GCP inspection-readiness strategy, plans, and cross-functional readiness activities, including readiness governance, mock inspection support, inspection logistics, and issue escalation.
  • Host, lead, and/or provide senior Quality support for GCP-related inspections.

About the Company

4D Molecular Therapeutics

Develops gene therapies using AAV vectors

4D Molecular Therapeutics develops gene therapies using its Therapeutic Vector Evolution platform to create adeno-associated virus (AAV) delivery vectors that transport therapeutic genes to patients’ cells. This clinical-stage biotech focuses on genetic diseases such as cystic fibrosis, delivering genetic material through engineered AAV vectors in targeted tissues. Its product approach involves R&D and clinical trials to test safety and efficacy, followed by commercialization through direct sales or partnerships with larger pharmaceutical companies. The company differentiates itself with a proprietary vector evolution technology that enables tailored, precise gene delivery and by pursuing funding and collaborations (e.g., with the Cystic Fibrosis Foundation) to advance therapies like 4D-710. The goal is to bring gene therapies to market to treat serious genetic diseases and improve patient outcomes, funded by equity investments, strategic partnerships, and future product sales.

Company size
201-500
Company stage
IPO
Headquarters
Emeryville, CA
Founded
2013

Recently Posted Jobs

Explore more opportunities at 4D Molecular Therapeutics

See more jobs